Cacace Angela M 4
4 · ARVINAS, INC. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Cacace Angela M
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-06-17+15,995→ 51,852 total - Award
Stock Option (right to buy)
2024-06-17+24,632→ 24,632 totalExercise: $24.94Exp: 2034-06-16→ Common Stock (24,632 underlying)
Footnotes (2)
- [F1]The restricted stock units (each, an "RSU") were granted by the issuer on June 17, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on June 17, 2025, with the remainder of the shares vesting on June 17, 2026.
- [F2]The option was granted by the Issuer on June 17, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on June 17, 2025, with the remainder of the shares vesting on June 17, 2026.